Skip to main content

Table 3 TAFI and F 1 + 2 levels by gender, age, BMI and stage in the gastric cancer group

From: Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

  TAFI Level P-value F 1 + 2 Level P-value
Gender Female 63.6 ± 22.7 0.32 483.7 ± 230.8 0.28
  Male 73.6 ± 39.1   598.3 ±379.2  
Age >60 (n = 21) 67.7 ± 32.1 0.52 614 ± 337.8 0.11
  ≤60 (n = 12) 73.5 ± 37.1   437.2 ± 280.5  
BMI >25 (n = 15) 65.7 ± 31.8 0.34 583.7 ± 328.7 0.47
  ≤25 (n = 18) 74.8 ± 34.8   521.3 ± 329.1  
Stages Stage 1a (n = 1) 93.3 0.92 484 0.81
Stage 1b (n = 0) -   -  
Stage 2 (n = 5) 68.2 ± 21.3   416.8 ± 80.9  
Stage 3a (n = 14) 69 ± 23.   609.5 ± 354.7  
Stage 3b (n = 4) 71.8 ± 34   575 ± 498.7  
  Stage 4 (n = 9) 66.9 ± 51.9   526.6 ± 321